Ukraine, Canada defence ministers discuss epidemiological situation in countries’ armed forces

Sur le même sujet

• 

  30 mai 2024 | Local, Aérospatial

  Exclusive: To help Airbus, Macron pressed Canada to ease Russia titanium sanctions

• 

  27 mars 2020 | Local, Aérospatial, Naval, Terrestre, C4ISR, Sécurité

  NRC COVID-19 response

  The Government of Canada is taking strong and quick action to protect our economy, and the health and safety of all Canadians during this global outbreak of the novel coronavirus (COVID-19). We are working with our partners as part of the collective effort to help find solutions to the COVID-19 outbreak: 1. The COVID-19 Challenges Procurement Program: NRC Industrial Research Assistance Program and Innovative Solutions Canada Purpose: This program will post challenges seeking near-to-market solutions from small and medium-sized businesses (fewer than 500 staff) that need financial support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to refine and sell their product or solution to meet a COVID-19 related need. NRC IRAP works with roughly 8,000 small and medium-sized businesses every year through its cross-Canada network of 255 industrial technology advisors and provides over $300 million in support to more than 3,000 technology development projects annually Through this initiative, the Public Health Agency of Canada (PHAC) and Health Canada (HC) will establish a number of challenges corresponding to needs of health providers to deal with COVID-19 NRC IRAP will partner with Innovative Solutions Canada to launch calls for proposals over the next few weeks to address challenges, fund development of solutions, and buy successful products and services needed to address COVID-19 Together, NRC IRAP and Innovative Solutions Canada will: post the PHAC and HC challenges (Innovative Solutions Canada) award Phase 1 funding to successful small and medium-sized businesses to develop a proof of concept for their solution (NRC IRAP) award Phase 2 funding to the firms with the best concepts so they can develop a working prototype (NRC IRAP) The NRC, PHAC, HC or another federal department or agency will then be able purchase the product for use against COVID-19. Innovative Solutions Canada already has challenges in development, which they will begin posting to their website in the coming days. These will continue as PHAC, HC, and health care providers request new topics. Companies with promising technology relevant to the COVID-19 challenges can register their technology or product by clicking on the Register button below. Register 2. The Pandemic Response Challenge Program: National Research Council of Canada Purpose: This program will build teams to address challenges requiring further research and development for solutions to meet COVID-19 related needs. The NRC will build these teams drawing on internal-to-government capacity and academic researchers who register using the button below to indicate their interest, and related areas of expertise and capabilities. The NRC will receive $15M to form dedicated teams to address challenges in the areas of greatest research and development (R&D) need in the fight against COVID-19. The NRC Pandemic Response Challenge Program will accelerate the development of diagnostics and medical countermeasures for a rapid front-line response to protect and treat Canadians. This national vehicle will convene the best Canadian and international researchers from academia and small and medium-sized businesses to collectively accelerate R&D to address specific COVID-19 gaps and challenges as identified by Canadian health experts. The Pandemic Response Challenge Program is currently structured around 3 main research areas: Rapid detection and diagnosis Therapeutics and vaccine development and Digital health. Researchers at Canadian and international universities, government departments, colleges, and highly innovative firms with relevant expertise can now register their interest to work with us on these challenges by clicking the Register button below. Funding is available to help cover the costs of research for academic institutions, small and medium-sized businesses, and other eligible recipients participating in the challenge teams. Over the coming weeks, we will post the specific R&D challenges, send information to registered researchers, and invite them to indicate the expertise and capabilities they can bring to a team. Register 3. Biomanufacturing capacity at Royalmount: NRC Human Health Therapeutics Research Centre Purpose: This initiative will result in a Good Manufacturing Practices platform to develop and scale up COVID-19 Canadian vaccine and therapy candidates. The NRC Biomanufacturing facility, located in the NRC's Royalmount Avenue building in Montréal, is used to develop and scale up processes to produce biological medicines and is managed by the Human Health Therapeutics Research Centre. As part of its development capacity, the facility is equipped with pilot-scale bioreactors (200 L and 500 L), which will be operationally available to produce up to 100,000 doses of vaccine per month within 6 months once a vaccine suitable for front-line responders is available. A $15 million investment will fund the certification of the facility for Good Manufacturing Practices compliance, and will enable production of material that will be used in humans, particularly for vaccines or therapeutics. This certification can also greatly increase the capacity for candidate vaccines or therapeutics to be quickly rolled out and clinically tested, particularly those originating from Canada. The work to refine and certify quality systems at the facility will include: bringing the existing facility to regulatory standards, installing equipment to expand capacity, and managing information. Once certified, this facility will be able to accelerate the scale-up production and testing of various types of vaccine candidates in the context of the current COVID-19 outbreak, including protein-based, viral vector-based, and antibody-based products. https://nrc.canada.ca/en/research-development/research-collaboration/nrc-covid-19-response

• 

  6 juillet 2020 | Local, Aérospatial, Naval, Terrestre, C4ISR, Sécurité

  New NAFTA comes into force Canada Day amid tariff threats, COVID-19 uncertainty

  BY CORMAC MACSWEENEY Posted Jun 30, 2020 9:17 am MDT OTTAWA – The new NAFTA will come into effect on Wednesday amid the economic uncertainty caused by the COVID-19 pandemic. The negotiations caused months of fear in business and economic circles, with U.S. President Donald Trump threatening to pull out of the trade agreement both our economies and Mexico rely on. But after ratification earlier this year, the new NAFTA — formally the U.S.-Mexico-Canada Agreement — comes into force appropriately on Canada Day, bringing with it protections for the auto parts sector, more American access to our dairy market, stricter labour rules for Mexico, and measures to reduce the prices of pharmaceutical drugs. Colin Robertson with the Canadian Global Affairs Institute says this deal gives businesses confidence that Canada still has privileged access to our largest trading partner, but the COVID-19 pandemic has left a lot of questions about the future of our economies. “What it will depend on will be the growth of both economies' ends. The pandemic puts the big question mark on recovery and what that means for the future, so that one I can't answer,” he says. Meanwhile, Marc Agnew with the Canadian Chamber of Commerce says the COVID-19 pandemic may delay some of the benefits we get from this deal. “I don't think the new NAFTA is going to, necessarily, have a chance to really show its true value, probably until two or three, four years down the line,” he explains. However, Agnew believes this is a vital deal, regardless, because it will give businesses in Canada the security and confidence to plan for the years ahead. He adds the moment is soured by Trump once again threatening tariffs on Canadian aluminium. “It runs exactly counter to both the kind of spirit and the intent of what we're trying to do with this agreement,” Agnew says. Canada and the U.S. do $2 billion in trade a day. The USMCA is expected to bring modest gains to Canada's economy, with close to a $7-billion boost in the next five years, “It's still the biggest, single bilateral trading relationship in the world,” Robertson notes. https://www.660citynews.com/2020/06/30/new-nafta-canada-day-tariff-threats-covid-19/